Impact of Blood Storage Duration on Physiologic Measures
RECAP
2 other identifiers
observational
390
1 country
4
Brief Summary
This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red blood cell units stored for at least 21 days, if they need any red blood cell transfusions during their hospital stay for the surgery. This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there will be differences between the two randomized treatment groups in how much the following measurements change, from shortly before a red blood cell transfusion to shortly after a red blood cell transfusion, and from before surgery to 24 hours after surgery:
- Oxygen saturation in the hand
- Oxygen saturation in the brain
- Blood flow in the small blood vessels under the tongue. The RECAP study will also investigate whether changes in the measurements listed above are associated with clinical outcomes, including
- The Multi-Organ Dysfunction Score
- Death from any cause
- Major cardiac events
- Major pulmonary events
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 9, 2011
CompletedFirst Posted
Study publicly available on registry
January 11, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedFebruary 2, 2017
July 1, 2014
3 years
January 9, 2011
February 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in thenar oxygenation saturation
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Outcomes (17)
Change in downslope of thenar oxygen saturation
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in upslope of thenar oxygen saturation
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in cerebral oxygenation
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in microvascular mean flow index
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Change in percent perfused vessels
From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
- +12 more secondary outcomes
Study Arms (2)
Shorter-storage red blood cell units
Red blood cell units stored \<= 10 days
Longer-storage red blood cell units
Red blood cell units stored \>= 21 days
Eligibility Criteria
Cardiac surgery patients enrolled in the RECESS study (NCT00991341) at selected hospitals
You may qualify if:
- Eligible and randomized in the RECESS study (NCT00991341)
- At least 18 years old
- Willing to comply with protocol and provide written informed consent for both RECESS and RECAP
- Scheduled to undergo coronary artery bypass (CABG), valve, or combined CABG plus valve surgery
You may not qualify if:
- Prior randomization into the RECESS or RECAP studies
- Undergoing off-pump cardiac surgery
- Undergoing a significant concomitant surgical procedure
- Known sickle cell disease
- Participation in a clinical trial (except observational studies or RECESS) within the previous 30 days
- Received any investigational product within prior 30 days
- Not able to be randomized in RECESS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (4)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (1)
Stowell CP, Whitman G, Granger S, Gomez H, Assmann SF, Massey MJ, Shapiro NI, Steiner ME, Bennett-Guerrero E. The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery. J Thorac Cardiovasc Surg. 2017 Mar;153(3):610-619.e2. doi: 10.1016/j.jtcvs.2016.11.029. Epub 2016 Nov 19.
PMID: 28027790RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Elliott Bennett-Guerrero, MD
Duke University
- PRINCIPAL INVESTIGATOR
Christopher Stowell, MD, PHD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2011
First Posted
January 11, 2011
Study Start
January 1, 2011
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
February 2, 2017
Record last verified: 2014-07